Form 144 Health Catalyst For: 26 February

Health Catalyst (HCAT) filed a Form 144 on February 26, 2026, indicating its intention to sell restricted securities in the public market, with the company's stock declining 2.23% following the announcement. This regulatory filing, submitted to the Securities and Exchange Commission (SEC), is required when insiders or large shareholders plan to sell unregistered securities acquired through private transactions or other restricted means. The timing of the filing comes during a period of increased scrutiny around insider trading activities and market transparency, particularly in the healthcare technology sector where Health Catalyst operates. While the specific details of the planned securities sale, including the number of shares and potential value, were not immediately disclosed in the filing, such announcements often provide insight into the company's insider sentiment and potential future stock performance.